Bill Snyder Archive — Page 102 of 118
-
March 13, 2014
Pharmacology forum set for March 18
“Safety Pharmacology” will be the topic of the 23rd annual Joel G. Hardman Student-Invited Pharmacology Forum Tuesday, March 18, in 202 Light Hall. -
March 13, 2014
Diabetes researchers track cells’ ability to regenerate
Vanderbilt University scientists have found evidence that the insulin-secreting beta cells of the pancreas, which are either killed or become dysfunctional in the two main forms of diabetes, have the capacity to regenerate. -
March 6, 2014
Multi-center effort targets lethal Ebola, Marburg viruses
Vanderbilt University researchers are collaborating in a multi-center, federally-funded project to develop ways to treat and prevent the highly lethal Ebola and Marburg virus infections. -
March 6, 2014
Mission focus key to meeting health care challenges: Balser
“There has never been a time when we need leaders more than today.” With these words, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the School of Medicine, began his quarterly conversation with colleagues at Wednesday’s Clinical Enterprise Leadership Assembly in Langford Auditorium. -
March 6, 2014
Discovery sheds new light on marijuana’s anxiety relief effects
An international group led by Vanderbilt University researchers has found cannabinoid receptors, through which marijuana exerts its effects, in a key emotional hub in the brain involved in regulating anxiety and the flight-or-fight response. -
March 3, 2014
Vanderbilt awarded $16.5 million agreement to determine how toxic agents affect human cells
Vanderbilt University has been awarded a Cooperative Agreement with the Defense Advanced Research Projects Agency and the Army Research Office that is worth up to $16.5 million over five years.